Bausch Health Companies Inc (BHC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bausch Health Companies Inc (BHC) has a cash flow conversion efficiency ratio of -0.213x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$230.00 Million ≈ $166.38 Million USD) by net assets (CA$-1.08 Billion ≈ $-782.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BHC equity financing ratio to measure how much of total assets are equity-financed.
Bausch Health Companies Inc - Cash Flow Conversion Efficiency Trend (1993–2025)
This chart illustrates how Bausch Health Companies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Bausch Health Companies Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Bausch Health Companies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bausch Health Companies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Disc Medicine Inc.
NASDAQ:IRON
|
-0.090x |
|
Solaria Energía y Medio Ambiente S.A
MC:SLR
|
0.024x |
|
Giantec Semiconductor Corp
SHG:688123
|
0.037x |
|
Shenzhen Kstar Science & Technology Co Ltd
SHE:002518
|
0.079x |
|
YAMAHA CORP.SP.ADR/1 O.N.
F:YHAA
|
N/A |
|
ATS CORP.
F:ATO0
|
0.064x |
|
StoneCo Ltd
NASDAQ:STNE
|
0.061x |
|
Lojas Renner S.A.
SA:LREN3
|
0.064x |
Annual Cash Flow Conversion Efficiency for Bausch Health Companies Inc (1993–2025)
The table below shows the annual cash flow conversion efficiency of Bausch Health Companies Inc from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see BHC company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CA$376.31 Million ≈ $272.22 Million |
CA$1.38 Billion ≈ $997.34 Million |
3.664x | +173.87% |
| 2024-12-31 | CA$-322.00 Million ≈ $-232.93 Million |
CA$1.60 Billion ≈ $1.16 Billion |
-4.960x | +60.59% |
| 2023-12-31 | CA$-82.00 Million ≈ $-59.32 Million |
CA$1.03 Billion ≈ $746.53 Million |
-12.585x | -349.48% |
| 2022-12-31 | CA$260.00 Million ≈ $188.08 Million |
CA$-728.00 Million ≈ $-526.62 Million |
-2.800x | +93.32% |
| 2021-12-31 | CA$-34.00 Million ≈ $-24.60 Million |
CA$1.43 Billion ≈ $1.03 Billion |
-41.941x | -2383.93% |
| 2020-12-31 | CA$605.00 Million ≈ $437.65 Million |
CA$1.11 Billion ≈ $803.68 Million |
1.836x | +38.98% |
| 2019-12-31 | CA$1.14 Billion ≈ $821.77 Million |
CA$1.50 Billion ≈ $1.09 Billion |
1.321x | +147.80% |
| 2018-12-31 | CA$2.81 Billion ≈ $2.04 Billion |
CA$1.50 Billion ≈ $1.09 Billion |
0.533x | +38.40% |
| 2017-12-31 | CA$5.94 Billion ≈ $4.30 Billion |
CA$2.29 Billion ≈ $1.66 Billion |
0.385x | -39.86% |
| 2016-12-31 | CA$3.26 Billion ≈ $2.36 Billion |
CA$2.09 Billion ≈ $1.51 Billion |
0.641x | +75.54% |
| 2015-12-31 | CA$6.03 Billion ≈ $4.36 Billion |
CA$2.20 Billion ≈ $1.59 Billion |
0.365x | -13.58% |
| 2014-12-31 | CA$5.43 Billion ≈ $3.93 Billion |
CA$2.29 Billion ≈ $1.66 Billion |
0.422x | +112.08% |
| 2013-12-31 | CA$5.23 Billion ≈ $3.79 Billion |
CA$1.04 Billion ≈ $753.74 Million |
0.199x | +12.73% |
| 2012-12-31 | CA$3.72 Billion ≈ $2.69 Billion |
CA$656.58 Million ≈ $474.96 Million |
0.177x | +4.62% |
| 2011-12-31 | CA$4.01 Billion ≈ $2.90 Billion |
CA$676.47 Million ≈ $489.35 Million |
0.169x | +215.02% |
| 2010-12-31 | CA$4.91 Billion ≈ $3.55 Billion |
CA$263.19 Million ≈ $190.39 Million |
0.054x | -79.89% |
| 2009-12-31 | CA$1.35 Billion ≈ $979.73 Million |
CA$360.90 Million ≈ $261.07 Million |
0.266x | +56.71% |
| 2008-12-31 | CA$1.20 Billion ≈ $869.22 Million |
CA$204.32 Million ≈ $147.81 Million |
0.170x | -35.25% |
| 2007-12-31 | CA$1.30 Billion ≈ $938.82 Million |
CA$340.85 Million ≈ $246.57 Million |
0.263x | -35.35% |
| 2006-12-31 | CA$1.28 Billion ≈ $929.45 Million |
CA$521.93 Million ≈ $377.56 Million |
0.406x | +12.50% |
| 2005-12-31 | CA$1.38 Billion ≈ $997.94 Million |
CA$498.11 Million ≈ $360.32 Million |
0.361x | +77.00% |
| 2004-12-31 | CA$1.36 Billion ≈ $982.59 Million |
CA$277.09 Million ≈ $200.44 Million |
0.204x | -36.22% |
| 2003-12-31 | CA$881.60 Million ≈ $637.73 Million |
CA$281.98 Million ≈ $203.98 Million |
0.320x | -19.04% |
| 2002-12-31 | CA$845.69 Million ≈ $611.76 Million |
CA$334.10 Million ≈ $241.69 Million |
0.395x | +56.58% |
| 2001-12-31 | CA$1.13 Billion ≈ $814.58 Million |
CA$284.12 Million ≈ $205.53 Million |
0.252x | -41.54% |
| 2000-12-31 | CA$237.46 Million ≈ $171.77 Million |
CA$102.49 Million ≈ $74.14 Million |
0.432x | +131.96% |
| 1999-12-31 | CA$435.30 Million ≈ $314.89 Million |
CA$81.00 Million ≈ $58.59 Million |
0.186x | -82.23% |
| 1998-12-31 | CA$51.20 Million ≈ $37.04 Million |
CA$53.60 Million ≈ $38.77 Million |
1.047x | +1738.12% |
| 1997-12-31 | CA$75.50 Million ≈ $54.62 Million |
CA$4.30 Million ≈ $3.11 Million |
0.057x | +137.53% |
| 1996-12-31 | CA$36.90 Million ≈ $26.69 Million |
CA$-5.60 Million ≈ $-4.05 Million |
-0.152x | -107.12% |
| 1995-12-31 | CA$14.60 Million ≈ $10.56 Million |
CA$31.10 Million ≈ $22.50 Million |
2.130x | +530.85% |
| 1994-12-31 | CA$7.70 Million ≈ $5.57 Million |
CA$2.60 Million ≈ $1.88 Million |
0.338x | -58.19% |
| 1993-12-31 | CA$-2.60 Million ≈ $-1.88 Million |
CA$-2.10 Million ≈ $-1.52 Million |
0.808x | -- |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more